PortfoliosLab logo

Aridis Pharmaceuticals, Inc. (ARDS)

Equity · Currency in USD · Last updated Apr 1, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Aridis Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $242 for a total return of roughly -97.58%. All prices are adjusted for splits and dividends.

ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ARDS

Aridis Pharmaceuticals, Inc.


Aridis Pharmaceuticals, Inc. had a return of -73.38% year-to-date (YTD) and -82.55% in the last 12 months. Over the past 10 years, Aridis Pharmaceuticals, Inc. had an annualized return of -55.74%, while the S&P 500 had an annualized return of 8.86%, indicating that Aridis Pharmaceuticals, Inc. did not perform as well as the benchmark.

1 month-43.91%3.51%
6 months-65.10%12.88%
1 year-82.55%-10.71%
5 years (annualized)-55.74%8.86%
10 years (annualized)-55.74%8.86%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aridis Pharmaceuticals, Inc. Sharpe ratio is -0.61. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History

Aridis Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Aridis Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aridis Pharmaceuticals, Inc. is 97.71%, recorded on Mar 31, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-97.71%Sep 5, 20181137Mar 31, 2023
-1.47%Aug 31, 20181Aug 31, 20181Sep 4, 20182
-1.15%Aug 15, 20184Aug 20, 20183Aug 23, 20187

Volatility Chart

Current Aridis Pharmaceuticals, Inc. volatility is 100.61%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)